News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Helen Y. Lee, PharmD, MBA

Articles by Helen Y. Lee, PharmD, MBA

Concern Still Warranted: Medication Burden and Persistence with Lipid-Lowering Drugs

ByJennifer M. Polinski, MPS, MS,Joshua J. Gagne, PharmD, MS. Reply by Teisha A. Robertson, PharmD, MBA,Catherine E. Cooke, PharmD, BCPS,Jingshu J. Wang, PhD, MPH,Fadia T. Shaya, PhD, MPS,Helen Y. Lee, PharmD, MBA

December 31st 2008

Effect of Medication Burden on Persistent Use of Lipid-Lowering Drugs Among Patients With Hypertension

ByTeisha A. Robertson, PharmD, MBA,Catherine E. Cooke, PharmD, BCPS,Jingshu Wang, PhD,Fadia T. Shaya, PhD, MPH,Helen Y. Lee, PharmD, MBA

November 14th 2008

This study assesses the effect of medication burden on persistent use of newly added lipid-lowering drugs among patients with hypertension.

Latest Updated Articles

Concern Still Warranted: Medication Burden and Persistence with Lipid-Lowering Drugs
December 31st 2008
Effect of Medication Burden on Persistent Use of Lipid-Lowering Drugs Among Patients With Hypertension
November 14th 2008

Trending on AJMC

5 Things to Know About the FDA's Peptide Reversal

Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial

FDA Approves First Orexin Agonist for Narcolepsy Type 1

Ochsner Health, Paradigm Health Partnership Expands Clinical Trial Access Across the Gulf South

Vutrisiran Associated With Slower Decline in Left Atrial Function in ATTR-CM